A short (3-day) course of azithromycin tablets versus a 10-day course of amoxycillin-clavulanic acid (co-amoxiclav) in the treatment of adults with lower respiratory tract infections and effects on long-term outcome

Authors: Hoepelman I.M.¹; Mollers M.J.; van Schie M.H.; Greefhorst A.P.M.; Schlosser N.J.J.; Sinninghe Damste E.J.; van de Moosdijk C.N.F.; Dalinghaus W.H.; Eland M.E.; Mol S.J.M.; Rozenberg-Arska M.

Source: International Journal of Antimicrobial Agents, Volume 9, Number 3, January 1998 , pp. 141-146(6)

Publisher: Elsevier

Key:

- Free Content

- New Content

- Subscribed Content

- Free Trial Content

Keywords: Acute exacerbation of chronic bronchitis; Azithromycin; Co-amoxiclav; Lower respiratory tract infection

Language: English

Document Type: Research article

DOI: 10.1016/S0924-8579(97)00043-5

Affiliations: 1: Department of Medicine, Division of Infectious Diseases and AIDS, University Hospital, PO Box 85.500, 3508 GA Utrecht, The Netherlands

This article is hosted on another website.

You may be required to register, activate a subscription or purchase the article before you can obtain the full text.

Proceed